Trial ID or NCT#

NCT01586910

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.

Single Arm: The purpose of this trial is to evaluate the safety and effectiveness of transcatheter aortic valve implementation (TAVI) in patients with sever symptomatic Aortic Stenosis (AS) at intermediate surgical risk with TAVI. This is a non-randomized phase of the pivotal clinical trial.

Official Title

Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)

Eligibility Criteria

Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Alan Yeung, MD
Alan Yeung, MD
Interventional cardiologist, Cardiologist
Li Ka Shing Professor in Cardiology
Thomas Burdon
D. Craig Miller, M.D.
D. Craig Miller, M.D.
Cardiovascular surgeon
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Celina Yong, MD, MBA, MSc
Assistant Professor of Medicine (Cardiovascular Medicine)

Contact us to find out if this trial is right for you.

CONTACT

Leigh Trautman, RN
(650) 725-3931